Centre for Social Research in Health, UNSW, 2017 The Adelaide Gay Community Periodic Survey is a cross-sectional survey of gay and homosexually active men recruited at a range of gay community sites in Adelaide. The major aim of the survey is to provide data on sexual, drug use and testing practices related to the transmission of HIV and other sexually transmissible infections (STIs) among gay...
February 2017 This free, public lecture, given by Associate Professor Martin Holt of the UNSW Centre for Social Research in Health, considers the radical shifts in HIV prevention associated with the use of HIV treatment and pre-exposure prophylaxis (PrEP). These prevention strategies provide new ways to safely avoid HIV, but also pose challenges to the ways communities understand, and potentially...
nam/aidsmap, Published: 22 February 2017 A study of PrEP users presented last week showed that PrEP users had very high rates of STI diagnosis – in the order of 20 times higher than among HIV-negative gay men in the general population. The evidence that STIs increased further while people were on PrEP was, however, a lot more ambiguous. The problem in proving that PrEP has any causal relationship...
nam/adismap, 15 November 2016 Data from the last ten years of the Australian Gay Community Periodic Surveys shows a steady decline in consistent condom use, with more gay men attempting to minimise their risk by serosorting or by having an undetectable viral load. While HIV-positive men appear to be increasingly confident in their low risk of HIV transmission, it is not clear that HIV-negative...
BETA Blog, September 8, 2016 How many doses of Truvada-based PrEP (pre-exposure prophylaxis) are needed to provide adequate protection against HIV? Might it be possible to take PrEP only before and after sex—instead of every day? A recent article published in The Lancet HIV provides insight into this very question. Read more here Access Lancet HIV abstract here (for full text please see your...
HIV Treatment Bulletin, 12 July 2016 The PARTNER study showing the impact of HIV treatment (ART) on reducing transmission will benefit millions of people globally. The results set a new challenge about whether transmission is anything other than a theoretical risk when someone is taking effective ART. This reverses the common assumption that, by definition, some level of risk always exists when...